NCFB

October 20, 2016October 20, 2016

#CHEST2016 – Bayer to Present New Data on PAH and Bronchiectasis Therapies

Bronchiectasis, News, Pulmonary Hypertension

Bayer announced it will be giving three oral presentations on lead investigative therapies Adempas (riociguat) for the treatment of pulmonary arterial hypertension (PAH), and ciprofloxacin DPI (dry powder for inhalation) to treat non-cystic ... Read more

June 8, 2015November 5, 2015

Vertex, Parion Collaboration to Advance Development of Potential Therapeutic Strategy for CF, Other Pulmonary Disorders

Cystic Fibrosis, News

Vertex recently announced a collaboration with Parion Sciences with the goal of developing investigational epithelial sodium channel (ENaC) inhibitors as potential therapies for cystic fibrosis (CF) and other pulmonary disorders. CF is ... Read more

March 3, 2015November 6, 2015

Non-Cystic Fibrosis Bronchiectasis Patients Affected Most by Pseudomonas Aeruginosa

Bronchiectasis, News

Researchers at the University of Milano-Bicocca in Italy published in the International Journal of Mycobacteriology their findings regarding the clinical outcome of patients with non-cystic fibrosis bronchiectasis with chronic lung infection ... Read more